The main purpose of this study was to develop a radiomics nomogram based on 18F-FDG PET/CT radiomic features combined with clinicopathological factors to predict the survival outcomes of patients diagnosed with lung adenocarcinoma with an epidermal growth factor receptor (EGFR) mutation. Here, EGFR is linked to lung adenocarcinoma.